Psychologists in Mountain Brk, AL Accepting Medicare
8 Psychologists found. Showing 1 - 8
 Dr. David Henry Tytell, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3828 Halbrook Ln, Mountain Brk, AL 35243 Phone: 954-670-3426 |
Dr. Daniel Joseph Sullivan, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4 Office Park Cir Ste 214a, Mountain Brk, AL 35223 Phone: 205-335-0691 Fax: 205-941-8074 |
Dr. David Goldberg, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 400 Office Park Dr Ste 120, Mountain Brk, AL 35223 Phone: 205-380-6304 Fax: 205-802-5371 |
 Stacy Levin Ladden, PSY.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 4 Office Park Cir Ste 215a, Mountain Brk, AL 35223 Phone: 205-414-6686 |
Barry L Adams, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3 Office Park Cir Ste 115, Mountain Brk, AL 35223 Phone: 205-912-2000 Fax: 205-945-1890 |
Andrea Hendricks, PH.D Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 402 Office Park Dr, Mountain Brk, AL 35223 Phone: 205-202-1428 |
Parker L Storey, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 3 Office Park Cir, Ste 310, Mountain Brk, AL 35223 Phone: 205-601-9466 |
Dr. Stephanie Bethke Stoll, PH.D., BCBA-D Psychologist - Clinical Child & Adolescent Medicare: Medicare Enrolled Practice Location: 4 Office Park Cir, Suite 215-a, Mountain Brk, AL 35223 Phone: 205-414-6686 Fax: 205-449-5959 |
News Archive
New method evaluates effectiveness of interventions in mitigating spread of HIV
Using genetic sequencing to understand the evolutionary relationships among pathogens, an international team of researchers-;including several from the Center for Drug Use and HIV/HCV Research at New York University-;has developed a new method to determine how effective interventions are against the spread of infectious diseases like HIV.
Ocular drug delivery: DSM awarded membership in PANOPTES EU Funded Consortium
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium's goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM's polyesteramide (PEA) biomaterials as a superior drug delivery technology.
Omecamtiv mecarbil fails to achieve primary endpoint in phase II ATOMIC-AHF study
Omecamtiv mecarbil, a cardiac myosin-activator, did not achieve its primary efficacy endpoint in reducing dyspnoea (shortness of breath) in patients with acute heart failure, according to the results of the phase II ATOMIC-AHF (Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure) study.
New postnatal mouse model closely mimics fetal brain abnormalities caused by Zika infection
A team of scientists led by researchers at the University of Georgia has developed a new mouse model that closely mimics fetal brain abnormalities caused by the Zika virus in humans.
› Verified 6 days ago
Counselors
Pharmacists
Clinical Social Workers
Psychologists
Dentists
Occupational Therapists